Skip to main content

Want a detailed portfolio tracker?

Performance analysis of IN8bio (INAB)

Annual Return

Over the past 3 years, INAB has had an average annual return of -70.86%, underperforming the benchmark SPY, which returned +19.31% annual.

Since Jul 30, 2021, INAB has had an average annual return of -66.71%, underperforming the benchmark SPY, which returned +12.68% annual.

202620252024202320222021
-46.15%-69.65%-81.38%-40.26%-47.38%-56.10%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-15.38%-13.64%-14.04%+0%+26.53%-24.19%-10.64%-46.15%
2025-0.39%+5.08%-38.29%+1.81%-12.43%-52.70%+1.43%+4.23%-2.70%-9.72%+1.54%+18.18%-69.65%
2024-5.80%-14.62%+6.31%-13.56%+16.67%-28.82%-0.83%-37.38%-48.67%+3.70%+8.93%-15.74%-81.38%
2023-0.61%-33.36%-15.03%+12.31%+108.22%-49.34%-23.38%-11.02%-0.95%-5.77%-15.31%+66.27%-40.26%
2022-23.23%+24.63%-20.71%-27.93%-7.92%+2.26%+12.39%+1.97%-22.01%-3.47%-10.77%+32.76%-47.38%
2021+0%-32.00%+0.74%+10.80%-22.79%-25.09%-56.10%

Drawdown analysis of IN8bio (INAB)

The maximum drawdown for the INAB was -99.60%, occurring on Dec 19, 2025. This drawdown has not yet recovered.

The current INAB drawdown is -99.58%.

Since Jul 30, 2021 INAB has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.60%Jul 30, 20211103Dec 19, 2025OngoingOngoingOngoing